CuraCell TX AB
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC (NCT07255664) | CuraCell TX AB | 2025-11-13 |
Track CuraCell TX AB automatically
Every clearance here is in the API, with alerts when new ones post.